share_log

Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14

Benzinga ·  Dec 19, 2024 22:54  · Ratings

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Equal-Weight and raises the price target from $12 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment